Stryker SYK MedSurg and Neurotechnology — Additions and adjustments

Other segment segments

Similar metrics at other companies

ACNEMEA — Additions/ Adjustments

$845.27M+2,151%

ACNAmericas — Additions/ Adjustments

$2.08M-98.0%

ACNAsia Pacific — Additions/ Adjustments

$12.33M-33.8%

BSXMedSurg — Goodwill acquired

$274M—

CBZBenefits and Insurance Services — Additions

$0—

BRGlobal Technology and Operations — Additions

$9.58M—

FAQ

What is Stryker's medsurg and neurotechnology — additions and adjustments?

Stryker (SYK) reported medsurg and neurotechnology — additions and adjustments of -$74M in Q1 2026.

How has Stryker's medsurg and neurotechnology — additions and adjustments changed year-over-year?

Stryker's medsurg and neurotechnology — additions and adjustments decreased by 109.0% year-over-year, from $818.75M to -$74M.

What is the long-term trend for Stryker's medsurg and neurotechnology — additions and adjustments?

Over 4 years (2021 to 2025), Stryker's medsurg and neurotechnology — additions and adjustments has grown at a 95.8% compound annual growth rate (CAGR), from $223M to $3.28B.

What does medsurg and neurotechnology — additions and adjustments mean?

This metric represents non-recurring or non-operational financial adjustments specific to the MedSurg and Neurotechnology business segment. It captures one-time costs, restructuring charges, or accounting adjustments that are excluded from core operating performance metrics to provide a clearer view of underlying segment profitability. These adjustments are critical for investors to understand the difference between reported segment earnings and normalized operational cash flow.